WOMMA lays out disclosure guidelines for social media

Share this article:
Social media marketers should make it easy for consumers to consider the source when products are being discussed, according to new disclosure guidelines from the Word of Mouth Marketing Association (WOMMA).

The WOMMA guidelines reflect Federal Trade Commission guidelines on endorsements and testimonials that went into effect last December.

Paul Rand, board president of WOMMA and president and CEO of the Zócalo Group, said WOMMA's guidelines are the “practical applications” of the FTC guidelines: how to do it across various channels, and how it will look.

Marketers using Twitter, for example, should use one of three hashtags with any post when disclosure is needed:

■  #spon, for sponsored
■  #paid, for paid
■  #samp, for sample

For commenting in online discussions, a short disclosure statement is needed, e.g., “I received [product or sample] from [company name],” or “I was paid by [company name]," according to the guidelines (pdf).

WOMMA also recommends posting a “Disclosure and Relationships Statement” on the profile page of video and photo-sharing sites, blogs and social networks. Rand said WOMMA's guidelines are not meant to be a replacement for legal counsel, but will hopefully aid marketers in adhering to FTC guidelines.   

"I have consistently found that disclosure creates a better connection with readers and individuals, because there's clarity about motivation and connection to a brand. There's not as much second guessing about whether certain information is trustworthy or not," said Rand.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...